ArticleReports of biochemistry & molecular biology2024
Synthesis and Anticancer Activity of Polymer Nanocomposites with Moringa- Extracted CuO and Ag
Article in Reports of biochemistry & molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to synthesize copper oxide (CuO) and silver oxide (Ag2O) nanoparticles using a green synthesis method involving moringa extract and incorporate them into polymer nanocomposites with polyacrolein. The objective was to evaluate their cytotoxicity against fibroblasts and glioblastoma cell lines. Methods: The CuO and Ag Results: AFM analysis showed nanoparticle sizes of 19.36 nm for Ag2O and 66.89 nm for CuO, while TEM images revealed nonhomogeneous spherical nanocomposites. FT-IR and XRD confirmed the successful incorporation of nanoparticles into the polymer matrix. TGA and DSC results demonstrated thermal stability and transitions of the nanocomposites. Cytotoxicity assays indicated significant inhibition of A172 glioblastoma cell proliferation with minimal impact on normal fibroblast cells, suggesting selective cytotoxicity. Conclusions: The polymer nanocomposites incorporating moringa-extracted CuO and Ag2O nanoparticles exhibited promising selective cytotoxicity against glioblastoma cells, indicating their potential use as anticancer agents. Further studies on in vivo applications and long-term stability are warranted to advance their biomedical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.